Call for participation: MOESIN Deficiency

To assess the highly variable clinical consequences and treatments of Moesin deficiency, collect real world evidence about this ultra rare disease, and ultimately to improve patient management, Isabelle André, Jean-Sébastien Diana and coworkers in Paris are performing an international registry study (XMAID international registry NCT06278337). If you care for a MOESIN-deficient patient and want to participate, please contact  Alexandrine.garrigue@inserm.fr  to participate in the study. Inclusion of new patients is possible till the end of 2024.